Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 33.39
-0.05 (-0.15%)
At close: Aug 17, 2026
Pharmaids Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 1.34 | 21.45 | 48.04 | 127.54 | 4.07 |
Short-Term Investments | - | - | - | - | 33.05 | - |
Cash & Short-Term Investments | 1.34 | 1.34 | 21.45 | 48.04 | 160.59 | 4.07 |
Cash Growth | -93.77% | -93.77% | -55.36% | -70.09% | 3841.48% | 103.44% |
Accounts Receivable | - | 34.29 | 31.28 | 26.79 | 20.54 | 13.39 |
Receivables | - | 34.29 | 31.28 | 26.79 | 20.54 | 13.39 |
Inventory | - | 4.11 | 121.84 | 35.91 | - | 8.88 |
Prepaid Expenses | - | - | 4.02 | 1.57 | - | - |
Other Current Assets | - | 70.18 | 44.48 | 23.01 | 2.02 | 0.34 |
Total Current Assets | - | 109.91 | 223.07 | 135.32 | 183.16 | 26.68 |
Property, Plant & Equipment | - | 286.18 | 491.8 | 384.59 | 21.06 | 4.81 |
Goodwill | - | 314.17 | 314.17 | 314.17 | - | - |
Other Intangible Assets | - | - | 5.45 | 5.45 | - | - |
Long-Term Accounts Receivable | - | - | - | - | - | 14.16 |
Long-Term Deferred Tax Assets | - | 122.78 | 105.03 | 66.68 | 27.08 | 3.56 |
Long-Term Deferred Charges | - | - | - | - | 1.21 | - |
Other Long-Term Assets | - | 39.58 | 59 | 7.21 | 0.85 | 61.92 |
Total Assets | - | 872.62 | 1,199 | 913.41 | 245.85 | 111.12 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 27.8 | 163.21 | 51.18 | 18.83 | 23.06 |
Accrued Expenses | - | 0.47 | 6.58 | 4.62 | 0.28 | - |
Short-Term Debt | - | - | 40.57 | 11.53 | - | - |
Current Portion of Long-Term Debt | - | 90.69 | 10.06 | 6.14 | - | - |
Current Portion of Leases | - | 6.42 | 7.93 | 7.13 | - | - |
Current Income Taxes Payable | - | - | 0.26 | - | - | - |
Other Current Liabilities | - | 114.71 | 58.53 | 35.16 | 2.14 | 1.35 |
Total Current Liabilities | - | 240.09 | 287.15 | 115.76 | 21.25 | 24.41 |
Long-Term Debt | - | 118.44 | 301.84 | 35.85 | - | - |
Long-Term Leases | - | 18.27 | 29.35 | 24.68 | - | - |
Pension & Post-Retirement Benefits | - | 1.79 | 7.78 | 6.15 | - | - |
Other Long-Term Liabilities | - | 18 | 22 | 26 | -0 | - |
Total Liabilities | - | 396.6 | 648.11 | 208.44 | 21.25 | 24.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 352.68 | 352.68 | 352.68 | 214.44 | 102.69 |
Additional Paid-In Capital | - | - | 505.75 | 505.75 | 104.24 | - |
Retained Earnings | - | - | -266.77 | -139.3 | -98.89 | -23.33 |
Comprehensive Income & Other | - | 123.86 | 1.55 | 1.34 | 4.81 | 7.36 |
Total Common Equity | 476.54 | 476.54 | 593.2 | 720.47 | 224.6 | 86.72 |
Minority Interest | - | -0.51 | -42.79 | -15.5 | - | - |
Shareholders' Equity | 476.03 | 476.03 | 550.42 | 704.97 | 224.6 | 86.72 |
Total Liabilities & Equity | - | 872.62 | 1,199 | 913.41 | 245.85 | 111.12 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 233.82 | 233.82 | 389.75 | 85.33 | - | - |
Net Cash (Debt) | -232.49 | -232.49 | -368.3 | -37.29 | 160.59 | 4.07 |
Net Cash Growth | - | - | - | - | 3841.48% | 103.44% |
Net Cash Per Share | -6.57 | -6.57 | -10.44 | -1.64 | 12.45 | 0.40 |
Filing Date Shares Outstanding | 35 | 35.47 | 35.27 | 35.27 | 21.49 | 10.31 |
Total Common Shares Outstanding | 35 | 35.47 | 35.27 | 35.27 | 21.49 | 10.31 |
Working Capital | - | -130.18 | -64.07 | 19.56 | 161.91 | 2.27 |
Book Value Per Share | 13.43 | 13.43 | 16.82 | 20.43 | 10.45 | 8.41 |
Tangible Book Value | 162.37 | 162.37 | 273.59 | 400.85 | 224.6 | 86.72 |
Tangible Book Value Per Share | 4.58 | 4.58 | 7.76 | 11.37 | 10.45 | 8.41 |
Land | - | - | 254.5 | 178.22 | - | - |
Buildings | - | - | 7.72 | 6.08 | - | - |
Machinery | - | - | 184.48 | 116.88 | - | 5.09 |
Construction In Progress | - | - | 45.3 | 70.01 | - | 4.5 |